Methods For Assaying For Antidepressant Therapy Markers

Abstract

The present invention relates generally to methods for assaying for agents that modify the association of G<SUB>salpha</SUB> with components of the plasma membrane or cytoskeleton of cells. The present invention also relates generally to methods of assaying for agents having antidepressant activity via analysis of the association of G<SUB>salpha</SUB> with components of the plasma membrane or cytoskeleton of cells using a fluorescent analog of G<SUB>salpha</SUB> and fluorescence resonance energy transfer (FRET).


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 4, 2008
  • Application: Sep 29, 2006
    US US 52994406 A
  • Priority: Sep 29, 2006
    US US 52994406 A
  • Priority: Feb 8, 2005
    US US 5351605 A
  • Priority: Jul 30, 2001
    US US 91823001 A
  • Priority: Jul 29, 2000
    US US 22187400 P

Download Citation


Sign in to the Lens

Feedback